Cancer-drug setback sends Merck shares down again

NEW YORK (Reuters) - A setback for Merck& Co's key cancer drug sent the drugmaker's stock swooning on Monday for a second straight session, putting the shares on track for their biggest two-day decline in more than eight years. (Source: Reuters: Health)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2A201ef
via IFTTT